Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 1

Results: 12

Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 109, doi. 10.1007/s11523-020-00785-z
By:
- Watson, Catherine H.;
- Broadwater, Gloria;
- Wong, Janice;
- Spinosa, Daniel;
- de Oca, Mary Katherine Montes;
- Datto, Michael;
- Green, Michelle;
- Hubbard, Christopher;
- McKinney, Matthew;
- McCall, Shannon J.;
- Havrilesky, Laura J.;
- Strickler, John H.;
- Berchuck, Andrew;
- Strickland, Kyle C.;
- Previs, Rebecca A.
Publication type:
Article
Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 27, doi. 10.1007/s11523-020-00784-0
By:
- Fazio, Nicola;
- Kulke, Matthew;
- Rosbrook, Brad;
- Fernandez, Kathrine;
- Raymond, Eric
Publication type:
Article
Correction to: SB8: A Bevacizumab Biosimilar.
Published in:
2021
By:
- Syed, Yahiya Y.
Publication type:
Correction Notice
Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 1, doi. 10.1007/s11523-020-00782-2
By:
- Yang, Xinrui;
- Yin, He;
- Kim, Richard D.;
- Fleming, Jason B.;
- Xie, Hao
Publication type:
Article
The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 77, doi. 10.1007/s11523-020-00781-3
By:
- Buder, Anna;
- Hochmair, Maximilian J.;
- Filipits, Martin
Publication type:
Article
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 47, doi. 10.1007/s11523-020-00767-1
By:
- Lebbé, Céleste;
- Italiano, Antoine;
- Houédé, Nadine;
- Awada, Ahmad;
- Aftimos, Philippe;
- Lesimple, Thierry;
- Dinulescu, Monica;
- Schellens, Jan H. M.;
- Leijen, Suzanne;
- Rottey, Sylvie;
- Kruse, Vibeke;
- Kefford, Richard;
- Raymond, Eric;
- Faivre, Sandrine;
- Pages, Celine;
- Gomez-Roca, Carlos;
- Schueler, Armin;
- Goodstal, Samantha;
- Massimini, Giorgio;
- Delord, Jean-Pierre
Publication type:
Article
Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 85, doi. 10.1007/s11523-020-00778-y
By:
- Laliberté, François;
- Raut, Monika;
- Yang, Xiaoqin;
- Germain, Guillaume;
- Nahar, Akash;
- Desai, Kaushal D.;
- MacKnight, Sean D.;
- Sen, Shuvayu S.;
- Duh, Mei Sheng
Publication type:
Article
Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 69, doi. 10.1007/s11523-020-00771-5
By:
- Zheng, Jenny;
- Yu, Yanke;
- Durairaj, Chandrasekar;
- Diéras, Véronique;
- Finn, Richard S.;
- Wang, Diane D.
Publication type:
Article
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.
Published in:
2021
By:
- Delord, Jean-Pierre;
- Italiano, Antoine;
- Awada, Ahmad;
- Aftimos, Philippe;
- Houédé, Nadine;
- Lebbé, Céleste;
- Pages, Celine;
- Lesimple, Thierry;
- Dinulescu, Monica;
- Schellens, Jan H. M.;
- Leijen, Suzanne;
- Rottey, Sylvie;
- Kruse, Vibeke;
- Kefford, Richard;
- Faivre, Sandrine;
- Gomez-Roca, Carlos;
- Scheuler, Armin;
- Massimini, Giorgio;
- Raymond, Eric
Publication type:
journal article
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 59, doi. 10.1007/s11523-020-00780-4
By:
- Lorusso, Domenica;
- Maltese, Giuseppa;
- Sabatucci, Ilaria;
- Cresta, Sara;
- Matteo, Cristina;
- Ceruti, Tommaso;
- D'Incalci, Maurizio;
- Zucchetti, Massimo;
- Raspagliesi, Francesco;
- Sonetto, Cristina;
- Sinno, Valentina;
- Ronzulli, Dominique;
- Giolitto, Serena;
- de Braud, Filippo
Publication type:
Article
Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 13, doi. 10.1007/s11523-020-00763-5
By:
- Li, Xiaoyang;
- Zheng, Yu;
- Yue, Fei
Publication type:
Article
Developing Symptom Lists for People with Cancer Treated with Targeted Therapies.
Published in:
2021
By:
- Sodergren, Samantha C.;
- Wheelwright, Sally J.;
- Fitzsimmons, Deborah;
- Efficace, Fabio;
- Sprangers, Mirjam;
- Fayers, Peter;
- Harle, Amelie;
- Schmidt, Heike;
- Bottomley, Andrew;
- Darlington, Anne-Sophie;
- Benson, Charlotte;
- Bredart, Anne;
- Hentschel, Leopold;
- Arraras, Juan Ignacio;
- Ioannidis, Georgios;
- Leahy, Michael;
- Lugowska, Iwona;
- Nicolatou-Galitis, Ourania;
- Petranovic, Duska;
- Rohde, Gudrun E
Publication type:
journal article